Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FL5TP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml syringes, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. XOLAIR (omalizumab) is a monoclonal antibody used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria, representing a specialized pharmaceutical product within the Defense Logistics Agency's medical supply distribution network.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor. The company holds a significant $499.999 billion Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valid through November 2026, which serves as the vehicle through which this delivery order was issued. As a crucial supplier in the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group distributes branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide, with this delivery order representing one of numerous firm fixed-price purchase orders issued against that master contract.
Quick answers
Who was awarded contract SPE2DB25FL5TP?
SPE2DB25FL5TP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FL5TP worth?
The government has obligated $1,547 on SPE2DB25FL5TP.
Is contract SPE2DB25FL5TP an order under another contract?
Yes. SPE2DB25FL5TP is a delivery order under SPE2DB22D9209, an indefinite delivery contract.
Was contract SPE2DB25FL5TP competed?
The extent of competition for SPE2DB25FL5TP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award